Amneal Pharmaceuticals, Inc Class A Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$6.68-$12.97
Market Cap
$4B
Shares Short
6M

Financials

See more
Revenue (12 Mos)
$2.9B
Revenue Growth (YoY)
11.7%
Gross Profit (12 Mos)
$1B
Diluted EPS
$0.01

News

See more

Yahoo Finance • 16 days ago

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

Yahoo Finance • 20 days ago

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease

Yahoo Finance • 23 days ago

Amneal to Participate in Upcoming Investor Conferences

Yahoo Finance • 24 days ago

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

About

CEO
Mr. Chirag K. Patel
CFO
Mr. Anastasios G. Konidaris
Address
400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
8,300